Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study
Alzheimer s & Dementia2021Vol. 17(8), pp. 1353–1364
Citations Over TimeTop 1% of 2021 papers
Adam M. Brickman, Jennifer J. Manly, Lawrence S. Honig, Danurys Sanchez, Dolly Reyes‐Dumeyer, Rafael Lantigua, Patrick J. Lao, Yaakov Stern, Jean Paul Vonsattel, Andrew F. Teich, David Airey, Nicholas K. Proctor, Jeffrey L. Dage, Richard Mayeux
Abstract
Blood-based AD biomarker concentrations are associated with pathological and clinical diagnoses and can predict future development of clinical AD, providing evidence that they can be incorporated into multi-ethnic, community-based studies.
Related Papers
- [The incidence of reversible dementia in 145 patients referred on suspicion of dementia].(2002)
- On the Concept of Ethnic Groups and Theories of Ethnicity(2003)
- Study on pathological diagnosis of pathological changes of 457 patients with atypical squamous cells(2008)
- A Study on Some Problems in Ethnic Education Based on an Investigation of Ethnic Minorities with Small Population(2003)
- Bird's View:Ethnic Groups Research in China——Comments on Ethnic Groups and Their Culture(2008)